Literature DB >> 12122280

Expression of multidrug resistance-associated markers, their relation to quantitative pathologic tumour characteristics and prognosis in advanced ovarian cancer.

Mariël Brinkhuis1, Miguel A Izquierdo, Jan P A Baak, Paul J van Diest, Peter Kenemans, George L Scheffer, Rik J Scheper.   

Abstract

Mean nuclear area has been consistently shown by different researchers to be a strong and independent prognostic factor in advanced ovarian carcinoma. However, the biological background of the prognostic value of nuclear area remains unclear. Others have found that the multidrug-resistance (MDR) related protein LRP has strong prognostic value. In the present study we have analysed whether the mean nuclear area and LRP are related in tumour tissue of the ovary obtained at the debulking operation before the administration of chemotherapy in 40 patients. The mitotic activity index, volume percentage epithelium, standard deviation of nuclear area and the other MDR-related proteins P-glycoprotein (JSB-1, MRK-16) and MRP have been investigated additionally for correlations and prognostic value. No correlations were found between the morphometrical features and MDR-related proteins. Mean nuclear area tended to be larger in LRP positive tumours, but the correlation was not significant. In multivariate analysis LRP-protein expression and mean nuclear area had independent prognostic value. Further studies are required to elucidate the biological background of the strong prognostic value of mean nuclear area in advanced ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12122280      PMCID: PMC4618973          DOI: 10.1155/2002/958436

Source DB:  PubMed          Journal:  Anal Cell Pathol        ISSN: 0921-8912            Impact factor:   2.916


  10 in total

Review 1.  Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies.

Authors:  Linjuan Xu; Jing Cai; Qiang Yang; Hui Ding; Liying Wu; Tao Li; Zehua Wang
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-18       Impact factor: 4.553

Review 2.  MVP and vaults: a role in the radiation response.

Authors:  Pedro C Lara; Martin Pruschy; Martina Zimmermann; Luis Alberto Henríquez-Hernández
Journal:  Radiat Oncol       Date:  2011-10-31       Impact factor: 3.481

3.  P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway.

Authors:  Limei Yan; Zeping He; Wei Li; Ning Liu; Song Gao
Journal:  Cell Cycle       Date:  2021-08-12       Impact factor: 5.173

4.  Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells.

Authors:  Donavon C Hiss; Gary A Gabriels; Peter I Folb
Journal:  Cancer Cell Int       Date:  2007-04-18       Impact factor: 5.722

5.  Long Noncoding RNA MIR4697HG Promotes Cell Growth and Metastasis in Human Ovarian Cancer.

Authors:  Li-Qian Zhang; Su-Qing Yang; Ying Wang; Qiao Fang; Xian-Jun Chen; Hong-Sheng Lu; Ling-Ping Zhao
Journal:  Anal Cell Pathol (Amst)       Date:  2017-01-10       Impact factor: 2.916

6.  Aloesin Suppresses Cell Growth and Metastasis in Ovarian Cancer SKOV3 Cells through the Inhibition of the MAPK Signaling Pathway.

Authors:  Li-Qian Zhang; Rong-Wei Lv; Xiang-Dong Qu; Xian-Jun Chen; Hong-Sheng Lu; Ying Wang
Journal:  Anal Cell Pathol (Amst)       Date:  2017-06-18       Impact factor: 2.916

7.  Circular RNA hsa_circ_0078607 suppresses ovarian cancer progression by regulating miR-518a-5p/Fas signaling pathway.

Authors:  Nan Zhang; Yue Jin; Qiubo Hu; Shanshan Cheng; Chao Wang; Zhiyou Yang; Yu Wang
Journal:  J Ovarian Res       Date:  2020-06-05       Impact factor: 4.234

8.  A Rare Class of New Dimeric Naphthoquinones from Diospyros lotus have Multidrug Reversal and Antiproliferative Effects.

Authors:  Abdur Rauf; Ghias Uddin; Bina S Siddiqui; Joseph Molnár; Ákos Csonka; Bashir Ahmad; Diana Szabó; Umar Farooq; Ajmal Khan
Journal:  Front Pharmacol       Date:  2015-12-16       Impact factor: 5.810

9.  LGR5 promotes epithelial ovarian cancer proliferation, metastasis, and epithelial-mesenchymal transition through the Notch1 signaling pathway.

Authors:  Wenxue Liu; Jing Zhang; Xupei Gan; Fangqian Shen; Xiaoming Yang; Na Du; Dandan Xia; Lei Liu; Lianqiao Qiao; Jufang Pan; Yunyan Sun; Xiaowei Xi
Journal:  Cancer Med       Date:  2018-05-18       Impact factor: 4.452

10.  PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer.

Authors:  Diyou Li; Yinglin Pan; Yating Huang; Ping Zhang; Xuhong Fang
Journal:  Anal Cell Pathol (Amst)       Date:  2018-09-02       Impact factor: 2.916

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.